Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,607 | 57,293 | 111,140 | 286,428 | 125,783 |
| Marketable Securities | 317,556 | 365,933 | 318,894 | 238,784 | 165,736 |
| Receivables | 4,182 | 3,399 | N/A | N/A | N/A |
| TOTAL | $353,247 | $432,375 | $434,580 | $530,823 | $296,231 |
| Non-Current Assets | |||||
| PPE Net | 54,042 | 48,394 | 34,774 | 31,381 | 29,457 |
| Investments And Advances | 59,793 | 11,571 | 89,170 | 16,119 | 0 |
| Other Non-Current Assets | 10,622 | 5,435 | 0 | 0 | 0 |
| TOTAL | $124,458 | $65,400 | $123,944 | $47,500 | $29,457 |
| Total Assets | $477,704 | $497,775 | $558,524 | $578,323 | $325,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,887 | 13,900 | 15,919 | 7,703 | 3,199 |
| Accrued Expenses | 14,529 | 10,099 | 16,615 | 19,095 | 13,048 |
| TOTAL | $38,666 | $41,156 | $77,848 | $79,738 | $16,608 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,586 | 15,900 | 16,519 | 23,242 | N/A |
| Other Non-Current Liabilities | 7,032 | 1,622 | 1,452 | 1,452 | 0 |
| TOTAL | $14,846 | $9,167 | $8,897 | $11,631 | $N/A |
| Total Liabilities | $53,512 | $50,323 | $86,744 | $91,369 | $16,608 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,569 | 105,766 | 105,693 | 105,683 | 105,645 |
| Common Shares | 11 | 11 | 11 | 11 | 10 |
| Retained earnings | -27,707 | -2,933 | 22,478 | 39,009 | -124,259 |
| Other shareholders' equity | -1,431 | -1,069 | -256 | -457 | -609 |
| TOTAL | $424,192 | $447,452 | $471,780 | $486,954 | $309,080 |
| Total Liabilities And Equity | $477,704 | $497,775 | $558,524 | $578,323 | $325,688 |